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We have previously shown that the b2 integrins CR3 and
CR4 physically and functionally interact with urokinase
receptors (uPAR) on neutrophil plasma membranes in
an oscillatory fashion. In this study we have analyzed
neutrophils from patient SC, a 34 y old African American
female, with aberrant skin window results and recurrent
perianal abscesses and pretibial lesions diagnosed as pyo-
derma gangrenosum. Although untreated migrating
normal neutrophils exhibited 20 s sinusoidal oscillations
in CR4-uPAR proximity, neutrophils from SC demon-
strated a faster oscillation (10 s) in the form of a flyback
sawtooth wave. This waveform mimicked that observed
for normal neutrophils treated with subsaturating doses
of the kinase inhibitors staurosporine, genistein, and
erbstatin. As b2 integrins are regulated by phosphoryl-
ation, we tested the hypothesis that the aberrant CR4-
uPAR proximity oscillations seen in SC’s neutrophils are
Pyoderma gangrenosum is a painful, chronic, and ulceratingskin condition. It is diagnosed on the basis of clinicalfeatures, as there are no characteristic laboratory or histo-pathologic features (Holt et al, 1980). Although adultpatients generally have an associated systemic abnormality
(arthritis, inflammatory bowel disease, etc.), pediatric patients may
present with disease at sites of trauma. The pathogenesis of pyoderma
gangrenosum is unknown due in part to its heterogeneity; however,
analysis of certain pediatric patients suggests aberrations in immunologic
function (Delescluse et al, 1972; Lazarus et al, 1972; Brandt et al, 1977;
Clayton, 1977; Holt et al, 1980). Aberrations in neutrophil function,
including motility and phagocytosis, have been reported (Miller and
Dooley, 1973; Hickman, 1983; Malech and Gallin, 1987; Teitel, 1996;
Adachi et al, 1998). Steroids and methotrexate have been reported to
be useful in the clinical management of disease (Teitel, 1996); however,
because the cellular and molecular nature of pyoderma gangrenosum
is not known, there is no rational basis for therapy. Recently, we have
described a pediatric onset case of pyoderma gangrenosum with an
Manuscript received December 30, 1997; revised March 19, 1998; accepted
for publication March 27, 1998.
Reprint requests to: Dr. Howard R. Petty, Department of Biological Sciences,
Wayne State University, Detroit, MI 48202.
Abbreviations: FMLP, N-formyl-methionyl-leucyl-phenylalanine; RET, res-
onance energy transfer.
1Dr. Shaya’s present address is Department of Internal Medicine, Oakwood
Hospital, Dearborn, MI 48123.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
154
due to defective kinase activity that might be balanced
by a decrease in phosphatase activity. When SC’s cells
are exposed to subsaturating concentrations of the phos-
phatase inhibitor pervanadate, this caused the CR4-uPAR
oscillations to become sinusoidal in shape with a 20 s
period, as seen in normal migrating neutrophils.
Although SC’s neutrophils were deficient in spontaneous
and N-formyl-methionyl-leucyl-phenylalanine-induced
polarization, 0.5 mM pervanadate returned cell polariza-
tion to nearly normal levels, thus paralleling the acquisi-
tion of normal receptor interactions. Inasmuch as SC’s
cellular phenotype is mimicked by kinase inhibitors and
corrected by phosphatase inhibitors, we suggest that a
mutation(s) affecting the kinetics of intracellular signaling
enzymes, but not blocking the pathway per se, may be
responsible for this clinical state. Key words: biochemical
oscillators/urokinase receptors. J Invest Dermatol 111:154–158,
1998
associated defect in neutrophil motility; this motile deficiency was, in
turn, traced to aberrent leukocyte integrin clustering and metabolic
oscillations. Thus, we have suggested that a subset of the pediatric-
onset pyoderma gangrenosum patients may be categorized at a dynam-
ical disease in neutrophil regulation and have begun rational changes
in patient therapy (Adachi et al, 1998).
Several years ago we were the first to identify lateral interactions
between leukocyte integrins and glycosylphosphatidylinositol-linked
membrane proteins (e.g., Zhou et al, 1993; Sehgal et al, 1993). Using
several experimental techniques, we and others have confirmed and
extended these findings on the inter-receptor interactions of leukocyte
integrins and other membrane proteins (e.g., Xue et al, 1994, 1997;
Krauss et al, 1994; Cao et al, 1995; Poo et al, 1995; Bohuslav et al,
1995; Wei et al, 1996; Sitrin et al, 1996; Annenkov et al, 1996; Worth
et al, 1996; Kindzelskii et al, 1996, 1997). A central feature of cell
motility is the rhythmic interactions of integrins and the substrate
(Springer, 1990). Recently, parallel results indicating rhythmic inter-
receptor interactions between CR4 and uPAR have been observed
(Kindzelskii et al, 1997). In this study, a patient with a mild form of
pediatric-onset pyoderma gangrenosum with aberrant skin-window
findings was evaluated. Neutrophil receptor properties of this patient
reveal the dynamical character of this disorder, as the defect is
associated with the kinetics of inter-receptor interactions in neutrophil
membranes.
MATERIALS AND METHODS
Materials Genistein and FMLP (N-formyl-methionyl-leucyl-phenylalanine)
were obtained from Sigma (St. Louis, MO). Staurosporine and erbstatin were
purchased from Calbiochem (La Jolla, CA).
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Preparation of neutrophils Human neutrophils were purified from the
peripheral blood of normal donors (American Red Cross, Detroit, MI) or
patient SC. All procedures were approved by the Internal Review Board with
informed consent from participants. Heparinized whole blood was subjected to
Histopaque (Sigma) step-density gradient centrifugation (Cao et al, 1995). The
remaining red blood cells were depleted by hypotonic lysis. The cell preparation
was µ95% neutrophils. The purified neutrophils were typically 95% viable, as
assessed by trypan blue exclusion.
Immunofluorescence labeling Mouse monoclonal antibodies to CR3 (anti-
Mo1, clone 44), the urokinase-type plasminogen activator receptor (clone
3B10), CR4, and FcγRIIIB were obtained as previously described (Zhou et al,
1993; Kindzelskii et al, 1997). All experiments used Fab or F(ab9)2 fragments
of antibodies. Antibody fragments were conjugated with fluorescein or rhod-
amine as described (Kindzelskii et al, 1997).
Fluorescence microscopy Optical microscopy of labeled cells was carried
out using a Zeiss axiovert microscope (Carl Zeiss, New York, NY) attached to
a Perceptics (Knoxville, TN) image processing system. A Zeiss temperature
stage was used to hold sample temperature to 37°C in all experiments. Differential
interference contrast microscopy was performed using Zeiss polarizers and
analyzers. The optical filters and data handling were as previously described for
differential interference contrast and epifluorescence microscopy (Zhou et al,
1993). Fluorescence images were collected using an intensified charge-coupled
device camera (Hamamatsu model XC-77). Resonance energy transfer (RET)
microscopy and quantitative RET measurements were performed as described
(Kindzelskii et al, 1997).
For quantitative analysis of cell shape, the total number of cells and the total
number of polarized cells, which are triangular in shape, were determined in
randomly selected but nonoverlapping fields. The total number of cells counted
for each condition varied from 250 to 500 cells per experimental sample. In
some cases 10–7 M FMLP was added to stimulate cells.
Case report SC is a 34 y old African American female who initially presented
to the Children’s Hospital of Michigan in 1972 with a perineal abscess at the
age of 13. On this initial visit, no treatment was initiated and the abscesses
healed spontaneously.
In 1975, SC presented to the Children’s Hospital of Michigan again with a
perineal abscess with a yellowish discharge. During this 1 mo hospital stay,
cultures grew out Escherichia coli and Streptococcus. SC, during this episode, also
developed pustular lesions throughout her lower extremities. Moreover, pain
and swelling developed in both knees, ankles, and the right wrist. The patient
could not perform her normal daily activities such as riding a bicycle or walking.
The erythrocyte sedimentation rate was 53 mm per h. X-rays of the knees
showed bilateral effusions; a right knee arthrocentsis was performed that showed
7680 leukocytes per cm3 with 80% neutrophils. Both the slit test and the frei
test were negative. A biopsy of the perineal lesion showed chronic granulomatous
infection. She was treated with oxacillin, prostaphlin, betadine dressings, local
wound care, and scheduled aspirin. The patient’s symptoms subsided and she
was discharged.
During 1975 the patient presented on three additional occasions to the
Children’s Hospital of Michigan with perineal abscesses as well as pustular skin
lesions throughout the legs and the hands (Fig 1). Cultures of the abscesses
during these episodes were sterile. Further diagnostic evaluation was remarkable
for an increase in IgA, a defective chemotaxis of neutrophils, and an absence
of mononuclear and macrophages in the skin window test. The patient was
again routinely managed with aggressive local wound care, sitz baths, and
betadine dressings.
Since 1975, SC has continued to experience frequent cutaneous lesions
consistent with the diagnosis of pyoderma gangrenosum. Various medical
treatments and multiple surgeries including skin grafting in the axilla and
perineum have been performed with little lasting success. More recently, SC
has also had a history of nondeforming arthritis.
RESULTS
Neutrophil receptor oscillations in pyoderma gangrenosum
resemble kinase-inhibited normal cells On the basis of the
patient’s clinical disease, the clinical laboratory findings, and our
previous observations concerning pyoderma gangrenosum (Adachi
et al, 1998), we tested the hypothesis that other forms of pyoderma
gangrenosum display defects in biochemical oscillators of neutrophils.
Normal neutrophils display sinusoidal oscillations of CR4-to-uPAR
proximity (Fig 2a) and NAD(P)H autofluorescence (Fig 3c) with
periods of µ20 s, as we have previously noted (Kindzelskii et al, 1997,
1998). When neutrophils are exposed to the chemotactic factor FMLP,
the oscillation period was reduced to about 10 s (Fig 2b) (Kindzelskii
Figure 1. Patient SC. (A) The pretibial, ulcerated skin lesions SC develops
when becoming symptomatic. These lesions are consistent with pyoderma
gangrenosum. (B) The perianal abscesses that persistently recur with patient SC.
Although these lesions often drain pus, they do not test positive for organisms.
et al, 1997). Importantly, when normal neutrophils are treated with
low subsaturating doses of kinase inhibitors to only partially block
enzyme action, a nonsinusoidal oscillation of increased frequency was
observed (Fig 2c–e). At high doses, kinase inhibitors block receptor
oscillations and cell motility in vitro. We therefore titered these reagents
to obtain the highest doses that did not block cell polarization. Thus,
we employed 0.05 µM staurosporine (Fig 2c), 150 µg genistein per
ml (Fig 2d), and 20 µg erbstatin per ml (Fig 2e). Under all of these
conditions CR4-uPAR proximity oscillations were observed to be in
the form of a flyback sawtooth waveform of increased frequency.
Therefore, several kinase inhibitors in addition to staurosporine
(Kindzelskii et al, 1997) affect the frequency and waveform of CR4-
uPAR oscillations.
When SC’s cells were tested using immunofluorescence microscopy,
no integrin clusters were observed at 37°C (data not shown). This
contrasts sharply with our previous study of a patient with more severe
disease (Adachi et al, 1998). Also in contrast to this previous study,
SC’s cells exhibited sinusoidal NAD(P)H oscillations (Fig 3f); however,
we discovered that SC’s neutrophils exhibited a flyback sawtooth
waveform in CR4-uPAR proximity (Fig 3d) with a period of
10.6 6 1.8 s (Table I). This waveform was similar to that previously
observed for staurosporin-treated normal cells; i.e., her cells behaved
as though they were exposed to a kinase inhibitor. Thus, SC’s
neutrophils exhibit a defect in the kinetics of CR4-uPAR oscillations,
not in their presence or absence – thus underscoring the dynamics of
the defect at the molecular level.
Pervanadate restores normal receptor oscillations We have
previously suggested that the oscillatory CR4-uPAR waveform is a
reflection of the oscillatory signal transduction apparatus (Kindzelskii
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Figure 2. Receptor oscillations of normal neutrophils. The RET signal
intensities (ordinate) are plotted versus time (abscissa). Cells were labeled
with Fab anti-CR4 and F(ab)92 anti-uPAR reagents as previously described
(Kindzelskii et al, 1997). Untreated normal migrating neutrophils exhibit a
sinusoidal oscillation in CR4-uPAR RET signal (a). When incubated with
10–7 M FMLP, a chemotactic factor, the oscillation period decreases to about
10 s (b). Incubation of normal neutrophils with suboptimal doses of kinase
inhibitors perturbs the period and waveform of RET oscillations. Samples
treated with 0.05 µM staurosporine (c), 150 µg genistein per ml (d), and 20 µg
erbstatin per ml (e) display oscillations of µ10 s as a flyback sawtooth waveform.
Figure 3. Receptor and metabolic oscillations of normals and pyoderma
gangrenosum patient SC. Signal intensities (ordinate) are plotted versus time
(abscissa). RET (a, b, d, e) and metabolic (c, f) oscillations for both normal
neutrophils (a–c) and pyoderma gangrenosum neutrophils from a patient not
undergoing active drug treatment (d–f) are shown. As we have reported, the
RET intensity emission sinusoidally oscillates on normal cells during migration
(a). Although the RET emission oscillated on cells from SC as well, a flyback
sawtooth waveform was observed for these cells under untreated conditions
(d). Because these results suggested reduced kinase action, we sought to
‘‘balance’’ this effect by reducing phosphatase activity using pervanadate.
Although 0.5 µM pervanadate causes a reverse sawtooth waveform in normal
cells (b), it restored sinuoidal oscillations in SC’s neutrophils (e). NAD(P)H
oscillations were sinusoidal in both normal and SC neutrophils (c, f).
et al, 1997). Because the CR4-uPAR waveform of SC’s cells resembled
that of cells exposed to kinase inhibitors, we tested the hypothesis that
inhibition of phosphatase activity could balance the diminished kinase
activity of the cells, as reflected in the oscillatory waveforms. When
0.5 µM pervanadate was added to normal neutrophils a reverse sawtooth
waveform was observed (the reverse of kinase inhibitors); the reduced
phosphatase activity increased the declination time of the oscillatory
wave (Fig 3b). The suboptimal dose of 0.5 µM pervanadate was
Table I. Quantitative analysis of cellular oscillations in
neutrophils from patient SCa
Period
No addition 10.5 µM pervanadate p
CR4-uPAR proximity 10.6 6 1.8 20.7 6 2.2 ,0.01
NAD(P)H 10.9 6 2.1 21.1 6 2.4 ,0.05
aQuantitative analyses of normal neutrophils were previously published (Kindzelskii et al,
1997). All experiments were repeated on at least three different days.
Figure 4. Morphology of SC’s neutrophils in vitro. Differential interference
contrast images of SC’s neutrophils are shown. Cells were viewed during
spontaneous polarization in vitro at 37°C. The patient’s cells do not polarize
normally (A); however, inclusion of 0.5 µM pervanadate enhances cell
polarization (B). Scale bar: 10 µm.
chosen because it was previously found to only partially inhibit
phosphatase activity and cell function (Bennett et al, 1993; Kindzelskii
et al, 1997). When 0.5 µM pervanadate was added to SC’s neutrophils,
the flyback sawtooth waveform was transformed into a sinusoidal
waveform (Fig 3e). Thus, inhibition of phosphatase activity balances
the retarded risetime in CR4-to-uPAR proximity to create a normal
oscillatory phenotype. Unexpectedly, the period of CR4-to-uPAR
proximity oscillations was increased to a normal level (20.7 6 2.2 s;
Table I), as previously associated with nonactivated neutrophils
(Kindzelskii et al, 1997). Thus, the dynamical properties of inter-
receptor interactions can be associated with clinical disorders.
Pervanadate restores cell polarization During these studies we
noted that SC’s neutrophils do not assume a triangular shape (or
polarization) during in vitro spontaneous locomotion, as normal neutro-
phils do (Fig 4A). Furthermore, in a separate study we have shown
that perturbation of intracellular oscillators into a normal sine wave
pattern returns cell polarization to a normal phenotype (Adachi et al,
1998). Therefore, we tested the hypothesis that staurosporine treatment,
which returns oscillations to a normal phenotype, might also affect cell
shape. Inasmuch as 0.5 µM pervanadate was optimal in restoring a
normal receptor oscillatory pattern, we treated SC’s neutrophils under
these conditions. Figure 4(B) shows a field of SC’s neutrophils treated
with 0.5 µM pervanadate at 37°C for 30 min. In comparing parts (A)
and (B) of Fig 4, the number of polarized cells is substantially enhanced
in the presence of 0.5 µM pervanadate. Quantitative data regarding
the increase in appropriately polarized cells during spontaneous and
FMLP-induced cell motility are listed in Table II. Therefore, pervanad-
ate exposure significantly increases normal neutrophil polarization
during both stimulated and unstimulated conditions. Because approxim-
ately one-half of adherent neutrophils are polarized for migration after
in vitro adherence (Albrecht and Petty, 1998), pervanadate returns cell
polarization to near normal levels. Thus, both dynamic receptor
properties and cell functional properties associated with locomotion
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Table II. Quantitative analysis of cellular polarization in
neutrophils from patient SCa
Percentage of cells polarized
Condition No addition 10.5 µM pervanadate p
Spontaneous polarization 18 6 6 40 6 8 ,0.009
FMLP-induced polarization 20 6 9 45 6 14 ,0.04
aThe experiments were performed on 250–500 different cells from two independent
blood samples, as the patient became noncompliant.
can be returned to a normal phenotype by subsaturating phosphatase
inhibition.
DISCUSSION
In this and a preceding paper (Adachi et al, 1998), we have
attempted to lay the groundwork for a rational understanding of
pyoderma gangrenosum as a dynamical disease. We have chosen to
study only those cases initially presenting in childhood to increase
the likelihood of obtaining cases with congenital, rather than
acquired, deficiencies. Moreover, the patients are known to have
in vivo dysfunctions in cell motility as evidenced by skin window
tests. Because pyoderma gangrenosum is a very broad and heterogen-
eous clinical phenotype, dozens or hundreds of genotypes could
account for the disorder. Thus, broad-based surveys of many patients
is descriptively useful in clinical diagnoses, but of little use in sorting
out cellular and molecular mechanisms. Thus, we have divided the
problem into manageable units on a case-by-case basis for the
present time, as the pediatric cases are relatively rare. This strategy
has led to a rapid increase in our understanding of pyoderma
gangrenosum and presents novel ideas for rational drug intervention.
Our studies show that patient SC has a dynamic disease affecting
the properties of neutrophil integrins. Although this has not been
causally demonstrated, it seems likely to be of some importance
given the skin window results and tissue damage. Based on insights
from prior basic research (Petty and Todd, 1996), we found that
the neutrophils of patient SC exhibited a kinetic CR4-to-uPAR
proximity profile in the form of a flyback sawtooth waveform. This
resembles the flyback sawtooth waveforms observed for normal
neutrophils incubated with the kinase inhibitor staurosporin (Kindzel-
skii et al, 1997). Thus, we suggest that SC has a mutation in an
integrin-associated kinase (e.g., Bohuslav et al, 1995). By treating
normal cells with kinase inhibitors, it may become possible to
identify the relevant integrin-associated kinases and thereby identify
the aberrant gene. Although we cannot eliminate the possibility
that cellular phosphatase activity increased, thereby generating the
observed waveform, we feel that this is unlikely because mutations
almost always decrease enzyme efficiency. We have also found that
the disregulated kinase-phosphatase oscillatory activity can be
‘‘balanced’’ in this patient by the addition of pervanadate, a
phosphatase inhibitor. Furthermore, at this same dose of pervanadate,
SC’s neutrophils return to a normal polarized morphology for
spontaneous or chemotactic factor induced migration (Table II).
Thus, normal oscillatory properties accompany a normal morphologic
phenotype. This was anticipated because we have previously shown
that conditions that normalize intracellular oscillatory biochemical
pathways restore normal cell polarization in cells from a severe case
of pyoderma gangrenosum (Adachi et al, 1998). Our work suggests
that in the future certain cases of pyoderma gangrenosum may be
responsive to phosphatase inhibitors; topical application of such
inhibitors for this specific defect is an interesting possibility.
One significant impediment to progress in understanding pyoderma
gangrenosum is the heterogeneity of disease. The above studies
suggest that it may be possible to subtype this disorder. We have
previously shown that patient KN has defects associated with integrin
clustering, integrin–uPAR interactions, and metabolic oscillations
(Adachi et al, 1998). Patient SC, with a more mild form of the
disease, has a deficiency in only the kinetics of integrin–uPAR
interactions. By characterizing the neutrophil defects in pediatric-
onset pyoderma gangrenosum patients, it may become possible to
dissect the pathophysiology of this ill-defined, heterogeneous disorder.
It is possible that the cellular aberrations in effector function noted
in these patients may be associated with other systemic problems.
This also underscores the multiple levels of defects associated with
disease and suggests the possibility of mapping through genetic
lesions the molecular pathway of neutrophil activation.
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